CompletedPhase 2NCT00064792
Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
Studying 46,XY difference of sex development due to a cholesterol synthesis defect
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Forbes Porter, M.D.
- Principal Investigator
- Forbes D Porter, M.D.Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Intervention
- Simvastatin Susp.(drug)
- Enrollment
- 23 enrolled
- Eligibility
- 4-18 years · All sexes
- Timeline
- 2003 – 2010
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00064792 on ClinicalTrials.gov